» Articles » PMID: 26780512

PTEN Recruitment Controls Synaptic and Cognitive Function in Alzheimer's Models

Abstract

Dyshomeostasis of amyloid-β peptide (Aβ) is responsible for synaptic malfunctions leading to cognitive deficits ranging from mild impairment to full-blown dementia in Alzheimer's disease. Aβ appears to skew synaptic plasticity events toward depression. We found that inhibition of PTEN, a lipid phosphatase that is essential to long-term depression, rescued normal synaptic function and cognition in cellular and animal models of Alzheimer's disease. Conversely, transgenic mice that overexpressed PTEN displayed synaptic depression that mimicked and occluded Aβ-induced depression. Mechanistically, Aβ triggers a PDZ-dependent recruitment of PTEN into the postsynaptic compartment. Using a PTEN knock-in mouse lacking the PDZ motif, and a cell-permeable interfering peptide, we found that this mechanism is crucial for Aβ-induced synaptic toxicity and cognitive dysfunction. Our results provide fundamental information on the molecular mechanisms of Aβ-induced synaptic malfunction and may offer new mechanism-based therapeutic targets to counteract downstream Aβ signaling.

Citing Articles

Genetically encoded biosensor for fluorescence lifetime imaging of PTEN dynamics in the intact brain.

Kagan T, Gabay M, Meenakshisundaram A, Levi Y, Eid S, Malchenko N Nat Methods. 2025; .

PMID: 39979596 DOI: 10.1038/s41592-025-02610-9.


AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.

Choquet D, Opazo P, Zhang H Transl Neurodegener. 2025; 14(1):8.

PMID: 39934896 PMC: 11817889. DOI: 10.1186/s40035-025-00470-z.


Unraveling the AKT/ERK cascade and its role in Parkinson disease.

Keshri P, Singh S Arch Toxicol. 2024; 98(10):3169-3190.

PMID: 39136731 DOI: 10.1007/s00204-024-03829-9.


The role of brown adipose tissue in mediating healthful longevity.

Zhang J, Kibret B, Vatner D, Vatner S J Cardiovasc Aging. 2024; 4(2).

PMID: 39119146 PMC: 11309368. DOI: 10.20517/jca.2024.01.


Biomarker profiling to determine clinical impact of microRNAs in cognitive disorders.

Zhai W, Zhao M, Wei C, Zhang G, Qi Y, Zhao A Sci Rep. 2024; 14(1):8270.

PMID: 38594359 PMC: 11004146. DOI: 10.1038/s41598-024-58882-2.


References
1.
Ortega-Molina A, Efeyan A, Lopez-Guadamillas E, Munoz-Martin M, Gomez-Lopez G, Canamero M . Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab. 2012; 15(3):382-94. DOI: 10.1016/j.cmet.2012.02.001. View

2.
Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

3.
Chen Q, Shimahara T, Xie C . Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem. 2002; 77(3):354-71. DOI: 10.1006/nlme.2001.4034. View

4.
Cohen E, Paulsson J, Blinder P, Burstyn-Cohen T, Du D, Estepa G . Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell. 2009; 139(6):1157-69. PMC: 3017511. DOI: 10.1016/j.cell.2009.11.014. View

5.
Holcomb L, Gordon M, McGowan E, Yu X, Benkovic S, Jantzen P . Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998; 4(1):97-100. DOI: 10.1038/nm0198-097. View